ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.

19 Mar 2025

ECO Animal Health - R&D Day - Investor Presentation video - 13 March 2025

David Hallas (CEO), Chris Wilks (CFO), senior leaders from ECO Animal Health and an industry expert presented at the company's R&D Day on 13th March.

The speakers shared valuable insights on how the next generation of assets in ECO's R&D pipeline are driving long-term value creation and future proofing the business through innovations in preventative animal health.

The full video has been divided into chapters, as below:
0:00:03 - Introduction - Dr. David Hallas (CEO)
0:14:01 - Investment case for preventative medicine - Dr. Simon Middleton
0:25:19 - ECO’s R&D pipeline overview - Dr. Hafid Benchaoui
0:44:18 - Best in class Mycoplasma vaccines - Dr. Nathalie Desloges
0:57:31 - Commercialisation pathway for ECOVAXXIN - Andrew Buglass (CCO)
1:14:18 - ECO’s next wave pipeline - Dr. Hafid Benchaoui
1:34:14 - Economic impact and forecasting - Chris Wilks (CFO)
1:46:54 - Summary
1:50:34 - Questions & Answers

Return to ECO Animal Health

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 3rd Floor, 80 Cheapside, London, EC2V 6EE

Website design & development by Breckenridge